» Authors » Rafael Simo

Rafael Simo

Explore the profile of Rafael Simo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 335
Citations 8180
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Popovic N, Lois N, Perez-Hoyos S, Simo R, Exalto L
J Alzheimers Dis . 2025 Mar; :13872877251318029. PMID: 40025711
Background: Individuals with type 2 diabetes have an increased risk of developing both vascular and Alzheimer's dementia. Objective: This prospective cross-sectional study assessed the screening ability of the standard Montreal...
2.
Martin-Saladich Q, Simo R, Herance J, Ballester M
Comput Methods Programs Biomed . 2025 Feb; 263:108674. PMID: 39978140
Background And Objective: Type 2 diabetes (T2D) is a prevalent disease characterized by insulin resistance (IR), leading to energy disruptions in myocardial cells and increasing cardiovascular (CV) risk. Current diagnostic...
3.
Li H, Jiang Z, Guan Z, Bao Y, Liu Y, Hu T, et al.
Sci Bull (Beijing) . 2025 Feb; PMID: 39947986
Diabetes poses a considerable global health challenge, with varying levels of diabetes knowledge among healthcare professionals, highlighting the importance of diabetes training. Large Language Models (LLMs) provide new insights into...
4.
Canz M, Baguna-Torres J, Huerta J, Isla-Magrane H, Zufiaurre-Seijo M, Salas A, et al.
Exp Eye Res . 2025 Feb; 252:110274. PMID: 39923911
The Lund MetS rat (BBDR.cg-Lepr.cp/LundRj) is a novel animal model that has a congenic leptin receptor deficiency (LepR) and males exhibit a variety of metabolic abnormalities mimicking the human metabolic...
5.
Rivas M, Abad M, Carnicero E, Pereda L, Corredor R, Martinez M, et al.
Diabetes Res Clin Pract . 2025 Jan; 220:112003. PMID: 39824258
In a prospective study we found that in hospitalized patients with diabetes the use of mid line venous catheter (MVC) resulted in a significantly lower rate of vascular complications than...
6.
Hernandez C, Ramos H, Letondor A, Simo R
Pharmaceuticals (Basel) . 2025 Jan; 17(12. PMID: 39770421
Early stages of diabetic retinopathy are currently considered an unmet medical need due to the lack of effective treatments beyond proper monitoring and control of glycemia and blood pressure. Sitagliptin...
7.
Llorian-Salvador M, Perez-Martinez D, Tang M, Duarri A, Garcia-Ramirez M, Deas-Just A, et al.
J Neuroinflammation . 2024 Dec; 21(1):328. PMID: 39716335
Background: The global incidence of type 2 diabetes (T2D) is rapidly increasing, with retinopathy being its most common complication and a leading cause of preventable blindness. Although the precise mechanisms...
8.
Ramos H, Augustine J, Karan B, Hernandez C, Stitt A, Curtis T, et al.
J Neuroinflammation . 2024 Nov; 21(1):312. PMID: 39616390
Impaired function of the retinal neurovascular unit (NVU) is an early event in diabetic retinopathy (DR). It has been previously shown that topical delivery of the dipeptidyl peptidase-4 (DPP-4) inhibitor...
9.
Simo-Servat O, Amigo J, Ortiz-Zuniga A, Sanchez M, Cuadra F, Santos M, et al.
Acta Diabetol . 2024 Sep; 62(3):423-428. PMID: 39240308
Aim: To evaluate the impact of a proactive action of a specialized diabetes team (SDT) on different health outcomes in patients hospitalized in high complexity surgery units, including solid organ...
10.
Sheng B, Pushpanathan K, Guan Z, Lim Q, Lim Z, Yew S, et al.
Lancet Diabetes Endocrinol . 2024 Jul; 12(8):569-595. PMID: 39054035
Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise care for people with diabetes and adapt treatments for complex presentations. However, the rapid advancement of AI...